Wednesday, June 29, 2011 – HIPAA Complimentary Webinar Series
Learn about the impact of current and proposed HIPAA and HITECH privacy and security regulations on the operations of life sciences companies, including pharmaceutical and medical device manufacturers, distributors and marketing companies.
- How life sciences companies fit into the HIPAA regulatory framework
- Accessing and using protected health information (PHI) for the purpose of research, including the role of patient authorizations and waivers
- Determining when it’s appropriate to execute data use agreements and business associate agreements
- Restrictions on the use of PHI for marketing purposes
Kimberly J. Kannensohn, Partner, McGuireWoods LLP
Holly Carnell, Associate, McGuireWoods LLP
For information on upcoming McGuireWoods seminars, visit our events section.